华润双鹤药业股份有限公司

About 华润双鹤药业股份有限公司

CRH Shuanghe Pharmaceutical Co., Ltd. is a large modern pharmaceutical enterprise whose main business covers new drug research and development, formulation production, pharmaceutical sales, pharmaceutical equipment, and raw material drug production. It was listed on the Shanghai Stock Exchange in 1997 (referred to as "Shuanghe Pharmaceutical", stock code 600062). Currently, it has more than 11,000 employees, with over 1,700 registered varieties and an annual production of more than 300 varieties. It has many well-known products such as large infusions, 0-grade, Glucophage, Lifuxing, Erxiekang, Kelisu, VEC granules, and small injections. It holds a leading domestic position in fields such as large infusions, cardiovascular, endocrine, and anti-infection. In 2010, the annual sales revenue reached 5 billion yuan, with an annual net profit of nearly 500 million yuan. CRH Shuanghe is committed to providing society with effective and high-quality medicines and medical solutions, promoting knowledge about safe medication use, advocating healthy lifestyles, actively supporting social welfare, and continuously contributing to improving the health and quality of life for all people.